Concerned about spiraling specialty drug costs, a major pharmaceutical company asked Buck’s Pharmacy team to review outpatient specialty drug claims billed through their medical plan to determine potential savings opportunities and administration efficiencies.
Related insights
Checklist: COVID-19 Compliance check-in
In 2021, employers are still feeling the impact of COVID-19 on their businesses, employees,...
Read moreSurvey: Compliance implications of the American Rescue Plan Act (ARPA) on employment, health, and welfare benefits
Employers and plan sponsors face challenges as they navigate the latest federal legislation intended...
Read moreSurvey: Talking to employees about vaccine hesitancy
Nearly one-third (30%) of U.S. employees plan to take a “wait and see” approach...
Read more